| Author |
Shlaes, David M.
|
| Subject |
Antibiotics.
|
|
Drug development.
|
|
Drug Industry -- economics.
|
|
Drug Resistance, Bacterial.
|
|
Anti-Bacterial Agents.
|
|
Drug Design.
|
|
Drug Resistance, Bacterial.
|
|
United States.
|
|
United States.
|
| Description |
1 online resource (viii, 106 pages) : illustrations (some color) |
|
polychrome rdacc |
| Bibliography Note |
Includes bibliographical references (pages 101-103) and index. |
| Contents |
1 The Perfect Storm; 2 The Miracle; 3 Resistance; 4 The FDA; 5 Europe; 6 The Industry; 7 Modest Proposals; 8 Conclusions; Bibliography; Index. |
| Summary |
Antibiotics are truly miracle drugs. As a class, they are one of the only ones that actually cure disease as opposed to most drugs that only help relieve symptoms or control disease. Since bacteria that cause serious disease in humans are becoming more and more resistant to the antibiotics we have today, and because they will ultimately become resistant to any antibiotic that we use for treatment or for anything else, we need a steady supply of new antibiotics active against any resistant bacteria that arise. However, the antibiotics marketplace is no longer attractive for large pharmaceutical. |
| Note |
Print version record. |
| ISBN |
9789048190577 |
|
9048190576 |
|
9789048190560 |
|
9048190568 |
| OCLC # |
676699503 |
| Additional Format |
Print version: Shlaes, David M. Antibiotics. Dordrecht ; New York : Springer, 2010 9789048190560 (OCoLC)620364836 |
|
Search 
Search 
Previous Item
Permanent Link
